- Home
- CAVA vs HOLX Comparison
CAVA vs HOLX Comparison
Compare CAVA & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAVA
- HOLX
- Stock Information
- Founded
- CAVA 2006
- HOLX 1985
- Country
- CAVA United States
- HOLX United States
- Employees
- CAVA N/A
- HOLX N/A
- Industry
- CAVA Restaurants
- HOLX Medical Electronics
- Sector
- CAVA Consumer Discretionary
- HOLX Health Care
- Exchange
- CAVA Nasdaq
- HOLX Nasdaq
- Market Cap
- CAVA 16.2B
- HOLX 16.7B
- IPO Year
- CAVA 2023
- HOLX 1990
- Fundamental
- Price
- CAVA $118.32
- HOLX $69.73
- Analyst Decision
- CAVA Buy
- HOLX Buy
- Analyst Count
- CAVA 13
- HOLX 14
- Target Price
- CAVA $142.85
- HOLX $88.92
- AVG Volume (30 Days)
- CAVA 2.1M
- HOLX 2.7M
- Earning Date
- CAVA 02-25-2025
- HOLX 02-05-2025
- Dividend Yield
- CAVA N/A
- HOLX N/A
- EPS Growth
- CAVA N/A
- HOLX 81.42
- EPS
- CAVA 0.46
- HOLX 3.32
- Revenue
- CAVA $913,488,000.00
- HOLX $4,030,300,000.00
- Revenue This Year
- CAVA $34.56
- HOLX $5.40
- Revenue Next Year
- CAVA $23.50
- HOLX $5.74
- P/E Ratio
- CAVA $256.11
- HOLX $21.00
- Revenue Growth
- CAVA 34.05
- HOLX N/A
- 52 Week Low
- CAVA $44.80
- HOLX $68.61
- 52 Week High
- CAVA $172.43
- HOLX $84.67
- Technical
- Relative Strength Index (RSI)
- CAVA 47.41
- HOLX 34.61
- Support Level
- CAVA $109.23
- HOLX $68.61
- Resistance Level
- CAVA $120.77
- HOLX $72.99
- Average True Range (ATR)
- CAVA 3.85
- HOLX 1.52
- MACD
- CAVA 1.13
- HOLX -0.09
- Stochastic Oscillator
- CAVA 78.77
- HOLX 19.02
About CAVA CAVA Group Inc.
Cava Group Inc owns and operates a chain of restaurants. It is the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. The company's dips, spreads, and dressings are centrally produced and sold in grocery stores. The company's operations are conducted as two reportable segments: CAVA and Zoes Kitchen. The company generates the majority of its revenue from the CAVA segment.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.